MDT-bridged Radical Therapy After Aumolertinib With MRD-guided Maintenance in EGFRm+ Unresectable Stage III NSCLC (APPROACH)
Clinical trial NCT04841811 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04841811
- Sponsor
- Guangdong Association of Clinical Trials
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-20
- Primary completion
- 2026-12-31
- Enrollment
- 192
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.